- Home
- TDC vs TXG Comparison
TDC vs TXG Comparison
Compare TDC & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDC | TXG |
|---|---|---|
| Founded | 1979 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TDC | TXG |
|---|---|---|
| Price | $30.46 | $23.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 14 |
| Target Price | ★ $35.00 | $16.82 |
| AVG Volume (30 Days) | 2.6M | ★ 2.6M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.38 | ★ 76.97 |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $2,156,000,000.00 | $245,893,000.00 |
| Revenue This Year | $0.12 | N/A |
| Revenue Next Year | $1.56 | $7.32 |
| P/E Ratio | $23.16 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $18.43 | $6.78 |
| 52 Week High | $41.78 | $23.56 |
Technical Indicators
Market Signals| Indicator | TDC | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 69.04 |
| Support Level | $27.94 | $11.62 |
| Resistance Level | $32.03 | $23.56 |
| Average True Range (ATR) | 2.11 | 1.40 |
| MACD | -0.09 | 0.46 |
| Stochastic Oscillator | 19.12 | 97.83 |
Price Performance
Historical ComparisonAbout TDC Teradata Corporation
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).